Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC

NCT03085966 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

BIOLOGICAL: autologous immune cell therapy

Sponsor

Shanghai AbelZeta Ltd.

Collaborators

[object Object]